ALDYSTRO

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ALDYSTRO wurde als Wortmarke am 12.10.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 03. April 2023

Markenform Wortmarke
Aktenzeichen 1694412
Länder Europäische Gemeinschaft Großbritannien
Basismarke US Nr. 97368281, 18. April 2022
Anmeldedatum 12. Oktober 2022
Ablaufdatum 12. Oktober 2032

Markeninhaber

215 First Street
Cambridge MA 02142
US

Markenvertreter

3724 Benson Drive Raleigh NC 27609 US

Waren und Dienstleistungen

05 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
30. März 2023 2023/13 Gaz EM Ablehnung
09. Februar 2023 2023/6 Gaz GB Ablehnung
12. Oktober 2022 2022/43 Gaz US Eintragung

ID: 141694412